The physiology and clinical utility of anti-Mullerian hormone in women.

@article{Dewailly2014ThePA,
  title={The physiology and clinical utility of anti-Mullerian hormone in women.},
  author={Didier Dewailly and Claus Y. Andersen and Adam H. Balen and Frank Broekmans and Nafi Dilaver and R{\'e}nato Fanchin and Georg Griesinger and Tom W. Kelsey and Antonio La Marca and Cornelius B Lambalk and Helen J. Mason and Scott B. Maresh Nelson and Jenny A Visser and W. Hamish B. Wallace and Richard A. Anderson},
  journal={Human reproduction update},
  year={2014},
  volume={20 3},
  pages={370-85}
}
BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been applied to a wide array of clinical applications, mainly based on its ability to reflect the number of antral and pre-antral follicles present in the ovaries. AMH has been suggested to predict the ovarian response to hyperstimulation of the ovaries for IVF and the timing of menopause, and to indicate iatrogenic damage to the ovarian follicle reserve. It has also been proposed as a surrogate for antral follicle count… CONTINUE READING
Highly Influential
This paper has highly influenced 10 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 120 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 188 references

Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. BJOG 2012a;119:1171–1179

  • A La Marca, E Papaleo, V Grisendi, C Argento, S Giulini, A. Volpe
  • 2012
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…